nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—connective tissue—salivary gland cancer	0.0413	0.12	CbGeAlD
Amlexanox—PDE4C—tongue—salivary gland cancer	0.0355	0.103	CbGeAlD
Amlexanox—IL3—lymphoid tissue—salivary gland cancer	0.0302	0.0876	CbGeAlD
Amlexanox—S100A13—neck—salivary gland cancer	0.0273	0.0793	CbGeAlD
Amlexanox—S100A13—connective tissue—salivary gland cancer	0.0196	0.0569	CbGeAlD
Amlexanox—S100A12—connective tissue—salivary gland cancer	0.0193	0.0561	CbGeAlD
Amlexanox—S100A13—epithelium—salivary gland cancer	0.0186	0.054	CbGeAlD
Amlexanox—S100A12—epithelium—salivary gland cancer	0.0183	0.0533	CbGeAlD
Amlexanox—IL3—lymph node—salivary gland cancer	0.017	0.0494	CbGeAlD
Amlexanox—FGF1—neck—salivary gland cancer	0.0168	0.0489	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—salivary gland cancer	0.0141	0.041	CbGeAlD
Amlexanox—FGF1—connective tissue—salivary gland cancer	0.0121	0.035	CbGeAlD
Amlexanox—FGF1—epithelium—salivary gland cancer	0.0114	0.0332	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—salivary gland cancer	0.00881	0.0256	CbGeAlD
Amlexanox—S100A13—lymph node—salivary gland cancer	0.00808	0.0235	CbGeAlD
Amlexanox—S100A12—lymph node—salivary gland cancer	0.00797	0.0231	CbGeAlD
Amlexanox—PDE4B—parotid gland—salivary gland cancer	0.00773	0.0224	CbGeAlD
Amlexanox—PDE4B—saliva-secreting gland—salivary gland cancer	0.0074	0.0215	CbGeAlD
Amlexanox—PDE4D—lymph node—salivary gland cancer	0.00532	0.0154	CbGeAlD
Amlexanox—FGF1—lymph node—salivary gland cancer	0.00497	0.0144	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—salivary gland cancer	0.00497	0.0144	CbGeAlD
Amlexanox—PDE4A—lymph node—salivary gland cancer	0.00471	0.0137	CbGeAlD
Amlexanox—PDE4B—lymph node—salivary gland cancer	0.00281	0.00815	CbGeAlD
Amlexanox—PDE4B—Signaling Pathways—WNT5B—salivary gland cancer	0.000473	0.000721	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGFR4—salivary gland cancer	0.000473	0.000721	CbGpPWpGaD
Amlexanox—FGF1—Immune System—DTX4—salivary gland cancer	0.000469	0.000716	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000468	0.000713	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FBXW7—salivary gland cancer	0.000465	0.000709	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000464	0.000708	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL17RD—salivary gland cancer	0.000457	0.000697	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—PTEN—salivary gland cancer	0.000455	0.000695	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	0.000455	0.000695	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.000455	0.000695	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAML3—salivary gland cancer	0.000452	0.000689	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—PTEN—salivary gland cancer	0.000451	0.000688	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—PIK3CA—salivary gland cancer	0.000451	0.000687	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.00045	0.000686	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—PTEN—salivary gland cancer	0.000447	0.000682	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—PTEN—salivary gland cancer	0.000445	0.000679	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000444	0.000677	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT5B—salivary gland cancer	0.000441	0.000673	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CREBBP—salivary gland cancer	0.000434	0.000661	CbGpPWpGaD
Amlexanox—FGF1—Disease—DTX4—salivary gland cancer	0.000433	0.000661	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000429	0.000654	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL17RD—salivary gland cancer	0.000426	0.00065	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DTX4—salivary gland cancer	0.000425	0.000647	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CYLD—salivary gland cancer	0.000424	0.000647	CbGpPWpGaD
Amlexanox—IL3—Immune System—MAP2K2—salivary gland cancer	0.000424	0.000647	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MC3R—salivary gland cancer	0.000423	0.000645	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—PTEN—salivary gland cancer	0.000422	0.000643	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAML3—salivary gland cancer	0.000418	0.000637	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—HRAS—salivary gland cancer	0.000417	0.000636	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FOXO3—salivary gland cancer	0.000416	0.000635	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—EP300—salivary gland cancer	0.000409	0.000624	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000409	0.000623	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FOXO3—salivary gland cancer	0.000409	0.000623	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000407	0.000621	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PRKDC—salivary gland cancer	0.000407	0.000621	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—JAG1—salivary gland cancer	0.000406	0.00062	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGFR4—salivary gland cancer	0.000405	0.000617	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000403	0.000615	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MC3R—salivary gland cancer	0.000402	0.000614	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FBXW7—salivary gland cancer	0.000398	0.000607	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FOXO3—salivary gland cancer	0.000392	0.000598	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAML3—salivary gland cancer	0.00039	0.000594	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF16—salivary gland cancer	0.000388	0.000592	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000387	0.000591	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000385	0.000588	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MC3R—salivary gland cancer	0.000372	0.000568	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NUP62—salivary gland cancer	0.000372	0.000568	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DTX4—salivary gland cancer	0.00037	0.000564	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000369	0.000562	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000369	0.000562	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000363	0.000554	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF16—salivary gland cancer	0.000358	0.000547	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000358	0.000547	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000357	0.000544	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DTX4—salivary gland cancer	0.000352	0.000536	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF16—salivary gland cancer	0.000351	0.000536	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MC3R—salivary gland cancer	0.000347	0.00053	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000347	0.000529	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000345	0.000526	CbGpPWpGaD
Amlexanox—FGF1—Disease—NUP62—salivary gland cancer	0.000344	0.000524	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000343	0.000523	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—PIK3CA—salivary gland cancer	0.000342	0.000521	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000341	0.00052	CbGpPWpGaD
Amlexanox—FGF1—Disease—VCAN—salivary gland cancer	0.000341	0.00052	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAP2K2—salivary gland cancer	0.00034	0.000518	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000337	0.000513	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FOXO3—salivary gland cancer	0.000336	0.000512	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—HRAS—salivary gland cancer	0.000336	0.000512	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000334	0.00051	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAP2K2—salivary gland cancer	0.000334	0.000509	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DTX4—salivary gland cancer	0.000325	0.000496	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—PIK3CA—salivary gland cancer	0.000321	0.00049	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000321	0.00049	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000321	0.00049	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—HRAS—salivary gland cancer	0.000321	0.000489	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—HRAS—salivary gland cancer	0.000319	0.000487	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000318	0.000486	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—HRAS—salivary gland cancer	0.000318	0.000484	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—HRAS—salivary gland cancer	0.000316	0.000482	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000316	0.000481	CbGpPWpGaD
Amlexanox—IL3—Immune System—CREBBP—salivary gland cancer	0.000315	0.000481	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000314	0.000479	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDH1—salivary gland cancer	0.000313	0.000477	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000311	0.000475	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAML2—salivary gland cancer	0.000311	0.000475	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—PTEN—salivary gland cancer	0.00031	0.000473	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—PTEN—salivary gland cancer	0.00031	0.000472	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF16—salivary gland cancer	0.000306	0.000466	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAML2—salivary gland cancer	0.000305	0.000465	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DTX4—salivary gland cancer	0.000303	0.000463	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PIK3CA—salivary gland cancer	0.000303	0.000462	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000302	0.000461	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000297	0.000454	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—PIK3CA—salivary gland cancer	0.000297	0.000454	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—HRAS—salivary gland cancer	0.000297	0.000453	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000297	0.000453	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000297	0.000453	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EP300—salivary gland cancer	0.000295	0.00045	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—HRAS—salivary gland cancer	0.000295	0.000449	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—salivary gland cancer	0.000293	0.000447	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000292	0.000446	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000292	0.000445	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF16—salivary gland cancer	0.000291	0.000444	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—HRAS—salivary gland cancer	0.000291	0.000443	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGFR4—salivary gland cancer	0.000287	0.000437	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000285	0.000434	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FBXW7—salivary gland cancer	0.000282	0.00043	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—HRAS—salivary gland cancer	0.00028	0.000427	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—HRAS—salivary gland cancer	0.000275	0.00042	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000274	0.000418	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF16—salivary gland cancer	0.000269	0.000411	CbGpPWpGaD
Amlexanox—FGF1—Disease—JAG1—salivary gland cancer	0.000266	0.000405	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAML2—salivary gland cancer	0.000266	0.000405	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR4—salivary gland cancer	0.000265	0.000404	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000263	0.000402	CbGpPWpGaD
Amlexanox—FGF1—Disease—FBXW7—salivary gland cancer	0.00026	0.000397	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JAG1—salivary gland cancer	0.00026	0.000397	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGFR4—salivary gland cancer	0.000259	0.000395	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000259	0.000395	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FBXW7—salivary gland cancer	0.000255	0.000389	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAML2—salivary gland cancer	0.000253	0.000385	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CREBBP—salivary gland cancer	0.000253	0.000385	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF16—salivary gland cancer	0.000251	0.000383	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDH1—salivary gland cancer	0.000251	0.000382	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CREBBP—salivary gland cancer	0.000248	0.000378	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000246	0.000376	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FOXO3—salivary gland cancer	0.000238	0.000363	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDH1—salivary gland cancer	0.000236	0.00036	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAML2—salivary gland cancer	0.000234	0.000357	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000228	0.000348	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JAG1—salivary gland cancer	0.000227	0.000346	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGFR4—salivary gland cancer	0.000226	0.000344	CbGpPWpGaD
Amlexanox—IL3—Immune System—PTEN—salivary gland cancer	0.000225	0.000343	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000225	0.000343	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FBXW7—salivary gland cancer	0.000222	0.000339	CbGpPWpGaD
Amlexanox—FGF1—Disease—FOXO3—salivary gland cancer	0.00022	0.000335	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—PIK3CA—salivary gland cancer	0.000219	0.000334	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—PIK3CA—salivary gland cancer	0.000218	0.000333	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAML2—salivary gland cancer	0.000218	0.000333	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JAG1—salivary gland cancer	0.000216	0.000329	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FOXO3—salivary gland cancer	0.000215	0.000328	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR4—salivary gland cancer	0.000215	0.000328	CbGpPWpGaD
Amlexanox—IL3—Immune System—EP300—salivary gland cancer	0.000215	0.000327	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FBXW7—salivary gland cancer	0.000211	0.000322	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CREBBP—salivary gland cancer	0.000204	0.000311	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—HRAS—salivary gland cancer	0.000203	0.000309	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—HRAS—salivary gland cancer	0.000202	0.000308	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JAG1—salivary gland cancer	0.0002	0.000304	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR4—salivary gland cancer	0.000199	0.000303	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FBXW7—salivary gland cancer	0.000196	0.000298	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAP2K2—salivary gland cancer	0.000194	0.000296	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000191	0.000292	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FOXO3—salivary gland cancer	0.000187	0.000286	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JAG1—salivary gland cancer	0.000186	0.000284	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR4—salivary gland cancer	0.000185	0.000283	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FBXW7—salivary gland cancer	0.000182	0.000278	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PTEN—salivary gland cancer	0.00018	0.000275	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAP2K2—salivary gland cancer	0.000179	0.000274	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FOXO3—salivary gland cancer	0.000178	0.000272	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PTEN—salivary gland cancer	0.000177	0.00027	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000176	0.000268	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000174	0.000265	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EP300—salivary gland cancer	0.000172	0.000262	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PTEN—salivary gland cancer	0.00017	0.000259	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EP300—salivary gland cancer	0.000169	0.000257	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FOXO3—salivary gland cancer	0.000165	0.000252	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—HRAS—salivary gland cancer	0.000161	0.000245	CbGpPWpGaD
Amlexanox—IL3—Immune System—PIK3CA—salivary gland cancer	0.000159	0.000242	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FOXO3—salivary gland cancer	0.000154	0.000235	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAP2K2—salivary gland cancer	0.000153	0.000233	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCND1—salivary gland cancer	0.000151	0.00023	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOTCH1—salivary gland cancer	0.000147	0.000224	CbGpPWpGaD
Amlexanox—IL3—Immune System—HRAS—salivary gland cancer	0.000147	0.000224	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000146	0.000222	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTEN—salivary gland cancer	0.000146	0.000222	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CREBBP—salivary gland cancer	0.000144	0.00022	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000144	0.00022	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDH1—salivary gland cancer	0.000143	0.000218	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EP300—salivary gland cancer	0.000139	0.000212	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000135	0.000205	CbGpPWpGaD
Amlexanox—FGF1—Disease—CREBBP—salivary gland cancer	0.000133	0.000203	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CREBBP—salivary gland cancer	0.000131	0.000199	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PIK3CA—salivary gland cancer	0.000127	0.000194	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000126	0.000192	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000125	0.000191	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PIK3CA—salivary gland cancer	0.000125	0.00019	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000123	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PIK3CA—salivary gland cancer	0.00012	0.000183	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000119	0.000182	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HRAS—salivary gland cancer	0.000118	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—HRAS—salivary gland cancer	0.000116	0.000176	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CREBBP—salivary gland cancer	0.000114	0.000173	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000111	0.00017	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HRAS—salivary gland cancer	0.000111	0.000169	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOTCH1—salivary gland cancer	0.00011	0.000168	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CREBBP—salivary gland cancer	0.000108	0.000165	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000107	0.000163	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTEN—salivary gland cancer	0.000103	0.000157	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HRAS—salivary gland cancer	0.000103	0.000157	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000103	0.000157	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CA—salivary gland cancer	0.000103	0.000157	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000102	0.000155	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CREBBP—salivary gland cancer	0.0001	0.000153	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—salivary gland cancer	9.93e-05	0.000151	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EP300—salivary gland cancer	9.83e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CA—salivary gland cancer	9.69e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—salivary gland cancer	9.66e-05	0.000147	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTEN—salivary gland cancer	9.52e-05	0.000145	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HRAS—salivary gland cancer	9.5e-05	0.000145	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.4e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CREBBP—salivary gland cancer	9.33e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTEN—salivary gland cancer	9.32e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CA—salivary gland cancer	9.22e-05	0.000141	CbGpPWpGaD
Amlexanox—FGF1—Disease—EP300—salivary gland cancer	9.08e-05	0.000138	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HRAS—salivary gland cancer	8.97e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EP300—salivary gland cancer	8.89e-05	0.000136	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CA—salivary gland cancer	8.54e-05	0.00013	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HRAS—salivary gland cancer	8.53e-05	0.00013	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—salivary gland cancer	8.41e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTEN—salivary gland cancer	8.12e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—salivary gland cancer	8e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HRAS—salivary gland cancer	7.9e-05	0.00012	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EP300—salivary gland cancer	7.74e-05	0.000118	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTEN—salivary gland cancer	7.72e-05	0.000118	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—salivary gland cancer	7.41e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EP300—salivary gland cancer	7.37e-05	0.000112	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PIK3CA—salivary gland cancer	7.27e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTEN—salivary gland cancer	7.15e-05	0.000109	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—salivary gland cancer	6.9e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EP300—salivary gland cancer	6.82e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HRAS—salivary gland cancer	6.73e-05	0.000103	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CA—salivary gland cancer	6.71e-05	0.000102	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTEN—salivary gland cancer	6.66e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CA—salivary gland cancer	6.58e-05	0.0001	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—salivary gland cancer	6.36e-05	9.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EP300—salivary gland cancer	6.36e-05	9.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—HRAS—salivary gland cancer	6.21e-05	9.47e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HRAS—salivary gland cancer	6.08e-05	9.28e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CA—salivary gland cancer	5.73e-05	8.73e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—salivary gland cancer	5.54e-05	8.45e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CA—salivary gland cancer	5.45e-05	8.31e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HRAS—salivary gland cancer	5.3e-05	8.08e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—salivary gland cancer	5.27e-05	8.04e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CA—salivary gland cancer	5.04e-05	7.69e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HRAS—salivary gland cancer	5.04e-05	7.69e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—salivary gland cancer	4.88e-05	7.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CA—salivary gland cancer	4.7e-05	7.17e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HRAS—salivary gland cancer	4.67e-05	7.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—salivary gland cancer	4.55e-05	6.94e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HRAS—salivary gland cancer	4.35e-05	6.63e-05	CbGpPWpGaD
